ECLINSO AG, a leading provider of clinical information technology, consulting and business process outsourcing services, announced today that it has entered into a strategic partnership agreement with XClinical GmbH.
Glycotope, a global leader in optimizing the glycosylation of biopharmaceuticals, has received the prestigious CPhI Innovation Gold Award.
Glycotope GmbH, a leading company in the field of glycomics, announced today the enrollment of the first patients in a phase I dose finding trial to evaluate safety and tolerability of TrasGEX™. TrasGEX™ is a biobetter of the marketed Trastuzumab / Herceptin™ targeting the HER2-receptor, commonly overexpressed in a variety of cancers.
The United States District Court for the Western District of Wisconsin, a jury awarded $52,009,941 in damages to Promega Corporation (Madison, WI) for infringing sales by Life Technologies (Carlsbad, CA).
The Promega App is now available in a new format optimized for easy use on both iPhone and iPad, and it's supplemented with more tools for scientists and students. New content in version 3.0 includes a Restriction Enzyme Finder, a new Biochemical Buffers chapter, and additional instructional videos on transfection and PCR purification.
Promega Corporation announces the launch of QuantiFluor™ RNA System for highly sensitive, easy RNA quantitation. The QuantiFluor RNA dye enables quantitation of small amounts (as little as 100pg) of RNA in solution; a critical step in many biological applications, particularly in standard molecular biology techniques.
Promega Corporation breaks ground today for a "Current Good Manufacturing Practice" (cGMP) facility dedicated to accommodate business growth and its customers who need FDA-regulated molecular biology products. These include components such as sample preparation systems and reagents which are part of diagnostic and medical tests sold by human diagnostic test providers
Promega announces the beta launch of the online gene exploration tool Find My Gene™.
Promega Corporation announced today the launch of highly sensitive bioluminescent assays for the measurement of the relative activities of histone deacetylases (HDAC) for basic research, screening and drug discovery. The new HDAC-Glo™ and SIRT-Glo™ Assays and Screening Systems use a single-reagent-addition, add-mix-measure protocol for easy implementation in bench top to high throughput screening applications, reducing labor and time to results.
Promega Corporation announced today that it has launched four new proteases, Pepsin, Elastase, Sequencing Grade Arg-C, and Thermolysin. These high quality proteases are the latest addition to Promega's market leading range of protein sample prep reagents, which includes Trypsin Gold.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.